A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse
- 17 July 2005
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 37 (8) , 803-805
- https://doi.org/10.1038/ng1603
Abstract
The mouse mutation fragilitas ossium (fro) leads to a syndrome of severe osteogenesis and dentinogenesis imperfecta with no detectable collagen defect. Positional cloning of the locus identified a deletion in the gene encoding neutral sphingomyelin phosphodiesterase 3 (Smpd3) that led to complete loss of enzymatic activity. Our knowledge of SMPD3 function is consistent with the pathology observed in mutant mice and provides new insight into human pathologies.Keywords
This publication has 14 references indexed in Scilit:
- Osteoblastic Cells Express Phospholipid Receptors and Phosphatases and Proliferate in Response to Sphingosine-1-PhosphateCalcified Tissue International, 2004
- Sphingomyelinases: enzymology and membrane activityFEBS Letters, 2002
- Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone diseaseBone, 2002
- Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization DefectJournal of Bone and Mineral Research, 2002
- Osteogenesis Imperfecta: Prospects for Molecular TherapeuticsMolecular Genetics and Metabolism, 2000
- Type V Osteogenesis Imperfecta: A New Form of Brittle Bone DiseaseJournal of Bone and Mineral Research, 2000
- Fragilitas ossium (fro/fro) in the mouse: A model for a recessively inherited type of osteogenesis imperfectaAmerican Journal of Medical Genetics, 1993
- Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragilityBone, 1991
- Fragilitas ossium: a new autosomal recessive mutation in the mouseJournal of Heredity, 1981
- Genetic heterogeneity in osteogenesis imperfecta.Journal of Medical Genetics, 1979